Conrad Pharma
ActiveHoldings and subsidiaries
4 holdingsHoldings 4
Source for every holding own accounts 2025
- DECAPHARsubsidiaryEquity €316,271 Profit of €82,626 in 2025 (profit of €61,243 in 2024) Checked score 91100%
- GEVA PHARMAsubsidiaryEquity €190,377 Profit of €81,596 in 2025 (profit of €86,846 in 2024) Checked score 95100%
- VERZELE PHARMAsubsidiaryEquity €166,349 Profit of €38,414 in 2025 (profit of €24,363 in 2024) Checked score 92100%
- VERZELE PHARMA ZWALMsubsidiaryEquity €183,267 Profit of €17,048 in 2025 (profit of €45,541 in 2024)100%
Board mandates elsewhere
1 board mandateBoard mandates of Conrad PharmaConrad Pharma sits on their board1
1 location
Companies at the same address
4 other companiesConnections & network
2 current directorsThe board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.